Tetrault Lynn A.

NeoGenomics, Inc. - Common Stock · Director

Tetrault Lynn A. is listed in public filings as director. This Tetrault Lynn A. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include NeoGenomics, Inc. - Common Stock (NEO), Alumis Inc. Common Stock (ALMS), Rhythm Pharmaceuticals, Inc. (RYTM), and Acelyrin, Inc. (SLRN). Investors use Tetrault Lynn A.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
NeoGenomics, Inc. - Common StockNEO--23.1k sharesGrant / ExerciseJun 1, 2026Disclosure amount unavailable23.1k shares----
NeoGenomics, Inc. - Common StockNEO--16k sharesGrant / ExerciseJun 1, 2026Disclosure amount unavailable16k shares----
NeoGenomics, Inc. - Common StockNEO$116k11.1k sharesGrant / ExerciseJun 1, 2026$116.4K11.1k shares$10.52--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Alumis Inc. Common StockALMS$204k49.8k sharesGrant / ExerciseJul 30, 2025$204.2K49.8k shares$4.10--
Rhythm Pharmaceuticals, Inc.RYTM$448k7k sharesGrant / ExerciseJun 24, 2025$448.0K7k shares$63.66--
Rhythm Pharmaceuticals, Inc.RYTM--4.7k sharesGrant / ExerciseJun 24, 2025Disclosure amount unavailable4.7k shares----
Rhythm Pharmaceuticals, Inc.RYTM--4k sharesGrant / ExerciseJun 18, 2025Disclosure amount unavailable4k shares----
NeoGenomics, Inc. - Common StockNEO--12.3k sharesGrant / ExerciseJun 1, 2025Disclosure amount unavailable12.3k shares----
NeoGenomics, Inc. - Common StockNEO--23.1k sharesGrant / ExerciseJun 1, 2025Disclosure amount unavailable23.1k shares----
NeoGenomics, Inc. - Common StockNEO$117k16.1k sharesGrant / ExerciseJun 1, 2025$117.3K16.1k shares$7.28--
Acelyrin, Inc.SLRN$090k sharesOtherMay 21, 2025$655.8K90k shares$7.29--
Acelyrin, Inc.SLRN$043.7k sharesOtherMay 21, 2025$194.8K43.7k shares$4.46--
NeoGenomics, Inc. - Common StockNEO$57k7k sharesBuyMay 9, 2025$57.0K7k shares$8.14--
NeoGenomics, Inc. - Common StockNEO--11.3k sharesGrant / ExerciseAug 10, 2024Disclosure amount unavailable11.3k shares----